At present, the developing novel drug for the treatment of Idiopathic Pulmonary Fibrosis (IPF) is targeted regulation of TGF-β signaling, and there is no similar competitive product in the world. The drug has now completed the pre-clinical research (GMP production and GLP safety assessment), and we are going to submit the application of first-in-c...
HTPEP-001, a new drug being developed by the company, was once again recognized by the international authoritative academic conference
Talent first, welcome to huitai home。
人才第一 talent and capacity
诚信利他 Honesty and altruism
专业精准 Profession and accuracy
协作赋能 Cooperation and empowerment
奋斗共赢 Loyalty and mutual-benefit